Marathon Capital Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-55,000
| Closed | -$179K | – | 98 |
|
|
2016
Q3 | $179K | Hold |
55,000
| – | – | 0.09% | 76 |
|
|
2016
Q2 | $184K | Hold |
55,000
| – | – | 0.09% | 69 |
|
|
2016
Q1 | $134K | Buy |
+55,000
| New | +$134K | 0.07% | 75 |
|
|
2015
Q4 | – | Sell |
-55,000
| Closed | -$189K | – | 95 |
|
|
2015
Q3 | $189K | Hold |
55,000
| – | – | 0.1% | 74 |
|
|
2015
Q2 | $73K | Hold |
55,000
| – | – | 0.03% | 92 |
|
|
2015
Q1 | $46K | Hold |
55,000
| – | – | 0.02% | 91 |
|
|
2014
Q4 | $22K | Buy |
55,000
+25,000
| +83% | +$10K | 0.02% | 87 |
|
|
2014
Q3 | $131K | Hold |
30,000
| – | – | 0.12% | 80 |
|
|
2014
Q2 | $149K | Sell |
30,000
-9,100
| -23% | -$45.2K | 0.12% | 78 |
|
|
2014
Q1 | $213K | Sell |
39,100
-2,550
| -6% | -$13.9K | 0.16% | 72 |
|
|
2013
Q4 | $253K | Sell |
41,650
-51,050
| -55% | -$310K | 0.18% | 62 |
|
|
2013
Q3 | $614K | Hold |
92,700
| – | – | 0.53% | 36 |
|
|
2013
Q2 | $470K | Buy |
+92,700
| New | +$470K | 0.4% | 43 |
|